New Delhi [India], May 25 (ANI): The Indian Council of Medical Research (ICMR), beneath the Department of Health Research, Ministry of Health and Family Welfare, on Monday efficiently organised ‘Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect’–India’s largest biomedical and expertise switch facilitation occasion, on the Manekshaw Centre, New Delhi.
The occasion marked the institution of one of many nation’s first structured platforms devoted to biomedical innovation, showcasing and expertise switch beneath the ICMR Medical Innovation Patent Mitra initiative. The initiative goals to translate indigenous biomedical analysis into accessible, real-world healthcare options by sturdy trade partnerships.
The occasion was inaugurated by Shri Prataprao Ganpatrao Jadhav, Union Minister of State (Independent Charge), Ministry of Ayush, and Minister of State, Ministry of Health and Family Welfare, within the presence of Prof. Gobardhan Das, Member, NITI.
Delivering the keynote deal with, the Minister of State Jadhav mentioned, ‘This initiative marks a decisive step in connecting Indian science with trade, guaranteeing that improvements developed in our laboratories translate into applied sciences that strengthen public well being and advance Viksit Bharat. India is shifting from being a shopper of well being applied sciences to turning into a world supply of inexpensive and progressive healthcare options, powered by establishments like ICMR and robust trade partnerships.’
Speaking on the event, Dr Gobardhan Das, Member, NITI Aayog, mentioned, ‘India has the scientific functionality and innovation ecosystem to emerge as a world chief in well being applied sciences. Medical Innovation Patent Mitra will play a vital position in defending mental property, enabling expertise switch and accelerating the journey of indigenous improvements from laboratories to society.’
Rajiv Bahl, Director General, ICMR and Secretary, Department of Health Research, mentioned, ‘Medical Innovations Patent Mitra displays ICMR’s dedication to making sure that cutting-edge analysis strikes past laboratories to succeed in individuals by sturdy trade partnerships and impactful expertise switch.’
During the occasion, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ have been additionally launched, marking a big step in direction of strengthening India’s biomedical innovation, mental property and expertise switch ecosystem.
A significant spotlight of the occasion was the switch of 41 public well being applied sciences from ICMR institutes and innovators to trade companions for additional improvement, manufacturing and commercialisation. These applied sciences embody superior diagnostics, vaccines, medical units and biomedical options addressing vital public well being priorities.
Among the applied sciences transferred have been glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, in addition to diagnostic applied sciences for illnesses corresponding to Japanese Encephalitis, Tuberculosis and Mpox.
In one other important first, well-characterised biomaterials, together with inactivated KFD and Chandipura viruses, have been additionally transferred to trade companions, strengthening India’s biomedical analysis and manufacturing ecosystem.
The occasion additionally showcased greater than 100 applied sciences in diagnostics, therapeutics and medical units developed by ICMR institutes, researchers and startups, whereas facilitating direct engagement between innovators and trade stakeholders.
The Innovators and Industry Connect initiative is predicted to play a pivotal position in strengthening India’s Biomedical sector for Viksit Bharat 2047 with a stronger Public-Private partnership. (ANI)